We have recently identified PR containing domain 14 (Prdm14) as a novel oncogene whose misexpression in hematopoietic precursors leads to B-cell differentiation block and, ultimately, lymphoblastic leukemia and lymphoma [10,11,12]. Here, PRDM14 is linked to acute lymphoblastic leukemia.